Confirm that all interventions and therapies are appropriately included in the economic evaluation. If any therapies are excluded from the economic evaluation, consider whether the SBA provides adequate justification for the exclusion. Reference the place in Section D where this is discussed in more detail. Describe any differences in the delivery/organisation of care between the intervention and main comparator. If there are differences, then note the strengths and weaknesses of the different models of care. State the clinical claim proposed in the SBA. For example, the intervention has superior safety and effectiveness, relative to the main comparator. If a clinical claim is not provided in the SBA, this should also be stated. PICO If the PICO were not presented to PASC or the MSAC executive, comment on whether the PICO chosen are appropriate.
Confirm that all interventions and therapies are appropriately included in the economic evaluation. If any therapies are excluded from the economic evaluation, consider whether the SBA provides adequate justification for the exclusion. Reference the place in Section D where this is discussed in more detail. Describe any differences in the delivery/organisation of care between the intervention and main comparator. If there are differences, then note the strengths and weaknesses of the different models of care. State the clinical claim proposed in the SBA. For example, the intervention has superior safety and effectiveness, relative to the main comparator. If a clinical claim is not provided in the SBA, this should also be stated. PICO If the PICO were not presented to PASC or the MSAC executive, comment on whether the PICO chosen are appropriate.
MSAC%20Assessment%20Report%20Critique%20Template%20-%20Therapeutic.docx